Location History:
- Olso, NO (2007)
- Oslo, NO (2015)
Company Filing History:
Years Active: 2007-2015
Title: Innovations of Bjørn Jarl Fagerlund in Sub-Dermal Pain Treatment
Introduction
Bjørn Jarl Fagerlund, an inventive mind based in Oslo, Norway, stands out for his contributions to the field of medical treatments. With two registered patents to his name, Fagerlund has dedicated his efforts to developing innovative solutions for specific health challenges. His work focuses particularly on the management of sub-dermal soft tissue pain, showcasing his commitment to improving patient outcomes.
Latest Patents
Fagerlund’s latest patents center around a significant breakthrough: a strontium compound for the treatment of sub-dermal soft tissue pain. This innovative method involves administering an effective amount of a physiologically tolerable strontium compound to alleviate pain in human or non-human subjects. The method emphasizes a non-invasive approach to one of the more challenging areas of pain management, opening new pathways for effective treatment options.
Career Highlights
Bjørn Jarl Fagerlund’s career has been marked by a deep focus on medical research and innovation. His role as an inventor and researcher at Santosolve AS reflects his dedication to enhancing therapeutic practices and patient care. The impact of his patents signifies a remarkable contribution to the healthcare industry, underlining the importance of innovative treatments in contemporary medicine.
Collaborations
Throughout his career, Fagerlund has collaborated with notable colleagues, including Egil Jellum and Clas Magne Kjølberg. These collaborations not only showcase the collective expertise in their field but also foster an environment of creativity and innovation. Teamwork in such endeavors often amplifies the potential for groundbreaking discoveries and advancements in treatment methods.
Conclusion
Bjørn Jarl Fagerlund’s contributions to the field of pain management through his innovative patents reflect the ongoing need for effective solutions in healthcare. His focus on strontium compounds highlights the potential for new methodologies in treating sub-dermal soft tissue pain. As research and innovation continue to evolve, Fagerlund’s work stands as a testament to the power of ingenuity in addressing complex medical challenges.